Guideline
doi: 10.1212/wnl.58.2.169.
Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]
- PMID: 11805241
- DOI: 10.1212/wnl.58.2.169
Item in Clipboard
Guideline
Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]
Neurology.
.
Erratum in
- Neurology 2002 Aug13;59(3):480
No abstract available
Comment in
-
Disease modifying therapies in multiple sclerosis.Neurology. 2002 Aug 13;59(3):471-2; author reply 472-3. doi: 10.1212/wnl.59.3.471. Neurology. 2002. PMID: 12177396 No abstract available.
-
Disease modifying therapies in multiple sclerosis.Neurology. 2002 Aug 13;59(3):472; author reply 472-3. Neurology. 2002. PMID: 12184316 No abstract available.
Similar articles
-
Current disease-modifying therapies in multiple sclerosis.Semin Neurol. 2003 Jun;23(2):133-46. doi: 10.1055/s-2003-41138. Semin Neurol. 2003. PMID: 12894379 Review.
-
Treatment of multiple sclerosis and related disorders: what's new in the past 2 years?Clin Neuropharmacol. 2003 Jan-Feb;26(1):28-37. doi: 10.1097/00002826-200301000-00007. Clin Neuropharmacol. 2003. PMID: 12567162 Review. No abstract available.
-
Disease-modifying drugs for multiple sclerosis: a rapid and systematic review.Health Technol Assess. 2000;4(9):i-iv, 1-101. Health Technol Assess. 2000. PMID: 10944743 No abstract available.
-
Immunologic therapy for relapsing-remitting multiple sclerosis.Curr Neurol Neurosci Rep. 2001 May;1(3):277-85. doi: 10.1007/s11910-001-0031-9. Curr Neurol Neurosci Rep. 2001. PMID: 11898530 Review.
-
Immunologic therapy for secondary and primary progressive multiple sclerosis.Curr Neurol Neurosci Rep. 2001 May;1(3):286-93. doi: 10.1007/s11910-001-0032-8. Curr Neurol Neurosci Rep. 2001. PMID: 11898531 Review.
Cited by
-
Benign multiple sclerosis: does it exist?Curr Neurol Neurosci Rep. 2012 Oct;12(5):601-9. doi: 10.1007/s11910-012-0292-5. Curr Neurol Neurosci Rep. 2012. PMID: 22777531 Review.
-
Fine Tuning of a Type 1 Interferon Antagonist.PLoS One. 2015 Jul 9;10(7):e0130797. doi: 10.1371/journal.pone.0130797. eCollection 2015. PLoS One. 2015. PMID: 26158644 Free PMC article.
-
Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions.World J Clin Cases. 2015 Jun 16;3(6):525-32. doi: 10.12998/wjcc.v3.i6.525. World J Clin Cases. 2015. PMID: 26090374 Free PMC article.
-
Socio-economic aspects of neuroimmunological diseases.J Neurol. 2006 Sep;253 Suppl 5:V87-90. doi: 10.1007/s00415-006-5015-x. J Neurol. 2006. PMID: 16998761 Review.
-
Evaluation of a Novel Preference Assessment Tool for Patients with Multiple Sclerosis.Int J MS Care. 2018 Nov-Dec;20(6):260-267. doi: 10.7224/1537-2073.2017-021. Int J MS Care. 2018. PMID: 30568563 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
